Department of Medicine 5 – Haematology and Oncology


close-button

Types of publications

Journal article
Book chapter / Article in edited volumes
Authored book
Translation
Thesis
Edited Volume
Conference contribution
Other publication type
Unpublished / Preprint

Publication year

From
To

Abstract

Journal

TAT-CRE inhalation enables tumor induction corresponding to adenoviral Cre-recombinase in a lung cancer mouse model (2025) Gewalt T, Dmitrieva AM, Elsner F, Zhao X, Sieber DD, Kocak IG, Yang Q, et al. Journal article PFS24 as a prognostic milestone in patients with newly diagnosed primary CNS lymphoma (2025) Zeremski V, Haage TR, Witte HM, Adolph L, Beer SA, Behre G, Jacobs B, et al. Journal article Effect of delayed isolation of peripheral blood mononuclear cells on cell viability and functionality (2025) Lehle S, Völkl S, Seitz K, Goossens C, Emons J, Rübner M, Uhrig S, et al. Journal article Deep learning-based image analysis in muscle histopathology using photo-realistic synthetic data (2025) Mill L, Aust O, Ackermann J, Burger P, Pascual M, Palumbo-Zerr K, Krönke G, et al. Journal article TGFα controls checkpoints in CNS resident and infiltrating immune cells to promote resolution of inflammation (2025) Lößlein L, Linnerbauer M, Zuber F, Tsaktanis T, Vandrey O, Peter A, Panier F, et al. Journal article TriCAM (NCT02976558) – a randomized controlled pilot study of complementary medicine in allogeneic stem cell transplantation to improve quality of life (2025) Behzad A, Krause S, Mackensen A, Müller F, Stark A, Völkl S, Rösler W Journal article Large B-cell lymphoma imprints a dysfunctional immune phenotype that persists years after treatment (2025) Pelzl R, Benintende G, Gsottberger F, Scholz JK, Rübner M, Yao H, Wendland K, et al. Journal article Limited association between HRR gene alterations and HRD in molecular tumor board cancer samples: Who should be tested for HRD? (2025) Schubart C, Tögel L, Carta MG, Hetzner P, Helbig L, Zaglas C, Ziegler M, et al. Journal article Outcomes of bispecific antibody therapy after CAR T-cell failure in relapsed/refractory large B-cell lymphoma (2025) Shumilov E, Scholz JK, Seib M, Mazzeo P, Wurm-Kuczera R, Vucinic V, Holtick U, et al. Journal article Selective H2-O Tissue Expression Reduces Risk for Graft-versus-Host Disease in an In Vivo Transplantation Model (2025) Zeun J, Bernhardt AL, Neubeck S, Lang V, Korn K, Nagel L, Kunert T, et al. Journal article